AI MARKET SCANNING

Incyte Corporation

🏛️ NASDAQ 📁 Healthcare 🏭 Biotechnology
AVG HISTORICAL GAP -0.91%
MAX GAP RECORD -9.64%
🔒 PRO INSTITUTIONAL AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡

SENTINEL HISTORICAL GAP VIEWER

// $INCY
📊 1-YEAR TIMELINE (GAPS PLOTTED) 🔮 SIMULATE SETUP 🔒
Bullish Opening Gap Bearish Opening Gap T-1 Close Baseline

CATALYSTS & GAP HISTORY

Oct 29, 2026 Earnings Release 2026-10-29 (BEFORE OPEN (08:00))
-4.48%
Jul 28, 2026 Earnings Release 2026-07-28 (BEFORE OPEN)
+0.63%
Apr 28, 2026 Earnings Release 2026-04-28 (AFTER CLOSE)
+1.47%
Feb 10, 2026 Earnings Release 2026-02-10 (BEFORE OPEN)
-5.53%
Oct 28, 2025 Earnings Release 2025-10-28 (BEFORE OPEN)
-1.01%
Jul 29, 2025 Earnings Release 2025-07-29 (BEFORE OPEN)
+2.62%
Apr 29, 2025 Earnings Release 2025-04-29 (BEFORE OPEN)
-0.79%
Feb 05, 2025 Earnings Release 2025-02-05 (BEFORE OPEN)
+0.64%

VOLATILITY & GAP BIAS

AVG GAP MOVE 2.4%
Bullish Gaps (5)
Bearish Gaps (6)
Neutral / Flat (5)

QUANTITATIVE LIVE RADAR BLOTTER

Algorithmic execution stream for $INCY

EXECUTIONS1 LOGS
STATUS🔒 ENCRYPTED
Execution Date Strategy & Setup Direction Execution Range Hold Time Net PnL
2026-10-29 🔒 PRO RADAR ••• x• $•••.•• → $•••.•• 8885m +9.38%
🔒 Real-Time Strategy Telemetry Protected

Exact execution levels, Trailing Stops, and live bot signals are reserved for PRO members.

UNLOCK LIVE RADAR ⚡

📖 Intelligence Summary

Incyte Corporation, a biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics in the United States, Europe, Canada, and Japan. The company offers JAKAFI for the treatment of myelofibrosis (MF), polycythemia vera, and steroid-refractory acute graft-versus-host disease; ICLUSIG, a kinase inhibitor to treat chronic myeloid leukemia and Philadelphia-chromosome…

NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗